Authors:
SRIDHARA R
EISENBERGER MA
SINIBALDI VJ
REYNO LM
EGORIN MJ
Citation: R. Sridhara et al., EVALUATION OF BIOMARKERS OF SURVIVAL RESPONSE IN HORMONE-REFRACTORY PROSTATE-CANCER PATIENTS TREATED WITH SURAMIN, Cancer epidemiology, biomarkers & prevention, 7(7), 1998, pp. 631-634
Authors:
SRIDHARA R
FRIMEL SM
ROENKER KP
PAN NR
ELLIOTT J
Citation: R. Sridhara et al., PERFORMANCE ENHANCEMENT OF GAINP GAAS HETEROJUNCTION BIPOLAR PHOTOTRANSISTORS USING DC BASE BIAS/, Journal of lightwave technology, 16(6), 1998, pp. 1101-1106
Authors:
EGORIN MJ
ROSEN DM
SRIDHARA R
SENSENBRENNER L
COTTLERFOX M
Citation: Mj. Egorin et al., PLASMA-CONCENTRATIONS AND PHARMACOKINETICS OF DIMETHYLSULFOXIDE AND ITS METABOLITES IN PATIENTS UNDERGOING PERIPHERAL-BLOOD STEM-CELL TRANSPLANTS, Journal of clinical oncology, 16(2), 1998, pp. 610-615
Authors:
SARKODEEADOO CB
KENDALL JM
SRIDHARA R
LEE EJ
SCHIFFER CA
Citation: Cb. Sarkodeeadoo et al., THE RELATIONSHIP BETWEEN THE DURATION OF PLATELET STORAGE AND THE DEVELOPMENT OF TRANSFUSION REACTIONS, Transfusion, 38(3), 1998, pp. 229-235
Citation: R. Sridhara, PREDICTION OF CARBOPLATIN CLEARANCE FROM STANDARD MORPHOLOGICAL AND BIOLOGICAL PATIENT CHARACTERISTICS, Journal of the National Cancer Institute, 89(20), 1997, pp. 1546-1547
Authors:
CONLEY BA
EGORIN MJ
SRIDHARA R
FINLEY R
HEMADY R
WU SL
TAIT NS
VANECHO DA
Citation: Ba. Conley et al., PHASE-I CLINICAL-TRIAL OF ALL-TRANS-RETINOIC ACID WITH CORRELATION OFITS PHARMACOKINETICS AND PHARMACODYNAMICS, Cancer chemotherapy and pharmacology, 39(4), 1997, pp. 291-299
Authors:
SARKODEEADOO C
OCONNELL B
SRIDHARA R
CAUDILL J
LEE E
COTTLERFOX M
Citation: C. Sarkodeeadoo et al., ARA-C VP-16 WITH G-CSF EFFECTIVELY MOBILIZES CD34+ CELLS FOR AUTOLOGOUS TRANSPLANTS (PBSCT)/, Blood, 90(10), 1997, pp. 4257-4257
Authors:
EISENBERGER MA
SINIBALDI VJ
REYNO LM
SRIDHARA R
JODRELL DI
ZUHOWSKI EG
TKACZUK KH
LOWITT MH
HEMADY RK
JACOBS SC
VANECHO D
EGORIN MJ
Citation: Ma. Eisenberger et al., PHASE-I AND CLINICAL-EVALUATION OF A PHARMACOLOGICALLY GUIDED REGIMENOF SURAMIN IN PATIENTS WITH HORMONE-REFRACTORY PROSTATE-CANCER, Journal of clinical oncology, 13(9), 1995, pp. 2174-2186
Authors:
REYNO LM
EGORIN MJ
EISENBERGER MA
SINIBALDI VJ
ZUHOWSKI EG
SRIDHARA R
Citation: Lm. Reyno et al., DEVELOPMENT AND VALIDATION OF A PHARMACOKINETICALLY BASED FIXED DOSING SCHEME FOR SURAMIN, Journal of clinical oncology, 13(9), 1995, pp. 2187-2195
Authors:
BROUN ER
SRIDHARA R
SLEDGE GW
LOESCH D
KNEEBONE PH
HANNA M
HROMAS R
CORNETTA K
EINHORN LH
Citation: Er. Broun et al., TANDEM AUTOTRANSPLANTATION FOR THE TREATMENT OF METASTATIC BREAST-CANCER, Journal of clinical oncology, 13(8), 1995, pp. 2050-2055
Authors:
SRIDHARA R
EISENBERGER MA
SINIBALDI VJ
REYNO LM
EGORIN MJ
Citation: R. Sridhara et al., EVALUATION OF PROSTATE-SPECIFIC ANTIGEN AS A SURROGATE MARKER FOR RESPONSE OF HORMONE-REFRACTORY PROSTATE-CANCER TO SURAMIN THERAPY, Journal of clinical oncology, 13(12), 1995, pp. 2944-2953
Authors:
MURRAY M
BRIZENDINE E
HAAG K
SRIDHARA R
BRATER C
Citation: M. Murray et al., EFFECTS OF NSAIDS ON ELECTROLYTE HOMEOSTASIS IN ELDERLY AND YOUNG PERSONS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 222-222
Authors:
DOYLE LA
ROSS DD
SRIDHARA R
FOJO AT
KAUFMANN SH
LEE EJ
SCHIFFER CA
Citation: La. Doyle et al., EXPRESSION OF A 95-KDA MEMBRANE-PROTEIN IS ASSOCIATED WITH LOW DAUNORUBICIN ACCUMULATION IN LEUKEMIC BLAST CELLS, British Journal of Cancer, 71(1), 1995, pp. 52-58
Authors:
BELANI CP
BELCHER AE
SRIDHARA R
SCHIMPFF SC
Citation: Cp. Belani et al., INSTRUCTION IN THE TECHNIQUES AND CONCEPT OF SUPPORTIVE CARE IN ONCOLOGY, Supportive care in cancer, 2(1), 1994, pp. 50-55
Authors:
JODRELL DI
REYNO LM
SRIDHARA R
EISENBERGER MA
TKACZUK KH
ZUHOWSKI EG
SINIBALDI VJ
NOVAK MJ
EGORIN MJ
Citation: Di. Jodrell et al., SURAMIN - DEVELOPMENT OF A POPULATION PHARMACOKINETIC MODEL AND ITS USE WITH INTERMITTENT SHORT INFUSIONS TO CONTROL PLASMA DRUG CONCENTRATION IN PATIENTS WITH PROSTATE-CANCER, Journal of clinical oncology, 12(1), 1994, pp. 166-175
Authors:
ROSS DD
WOOTEN PJ
TONG Y
CORNBLATT B
LEVY C
SRIDHARA R
LEE EJ
SCHIFFER CA
Citation: Dd. Ross et al., SYNERGISTIC REVERSAL OF MULTIDRUG-RESISTANCE PHENOTYPE IN ACUTE MYELOID-LEUKEMIA CELLS BY CYCLOSPORINE-A AND CREMOPHOR EL, Blood, 83(5), 1994, pp. 1337-1347
Authors:
ABRAMS JS
EISEMAN JL
MELINK TJ
SRIDHARA R
HIPONIA DJ
BELL MM
BELANI CP
ADLER WH
AISNER J
Citation: Js. Abrams et al., IMMUNOMODULATION OF INTERLEUKIN-2 BY CYCLOPHOSPHAMIDE - A PHASE-IB TRIAL, Journal of immunotherapy with emphasis on tumor immunology, 14(1), 1993, pp. 56-64
Authors:
REYNO LM
EGORIN MJ
CANETTA RM
JODRELL DI
SWENERTON KD
PATER JL
BURROUGHS JN
NOVAK MJ
SRIDHARA R
Citation: Lm. Reyno et al., IMPACT OF CYCLOPHOSPHAMIDE ON RELATIONSHIPS BETWEEN CARBOPLATIN EXPOSURE AND RESPONSE OR TOXICITY WHEN USED IN THE TREATMENT OF ADVANCED OVARIAN-CANCER, Journal of clinical oncology, 11(6), 1993, pp. 1156-1164
Authors:
ROSS DD
WOOTEN PJ
SRIDHARA R
ORDONEZ JV
LEE EJ
SCHIFFER CA
Citation: Dd. Ross et al., ENHANCEMENT OF DAUNORUBICIN ACCUMULATION, RETENTION, AND CYTOTOXICITYBY VERAPAMIL OR CYCLOSPORINE-A IN BLAST CELLS FROM PATIENTS WITH PREVIOUSLY UNTREATED ACUTE MYELOID-LEUKEMIA, Blood, 82(4), 1993, pp. 1288-1299